The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

NCT01181986 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

FED

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exenatide SC
DRUG: Exenatide IV
DRUG: Placebo SC
DRUG: Exendin-9
DRUG: Placebo IV

Sponsor

Carl T. Hayden VA Medical Center

Collaborators

[object Object]
[object Object]